Zhongshan Hospital (xiamen), Fudan University
Clinical trials sponsored by Zhongshan Hospital (xiamen), Fudan University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New oral drug chidamide tested for Hard-to-Treat bone marrow disorder Results expected Mar 2027 (estimated)
- New 'Off-the-Shelf' CAR-T therapy takes on Hard-to-Treat myeloma Results expected Sep 2027 (estimated)
-
Simpler stomach bug treatment on the horizon?
Disease control CompletedThis study tested different combinations of the acid-blocker tegoprazan with antibiotics to treat H. pylori, a common stomach infection. 640 adults who had never been treated before received one of several drug regimens for 14 days. The goal was to see which combination worked be…
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Scientists map gut bugs in double infection
Knowledge-focused CompletedThis study looked at 42 adults with both H. pylori infection and small intestinal bacterial overgrowth (SIBO). Researchers used advanced DNA and chemical tests on stool samples to map the types of gut bacteria and their byproducts. The goal was to better understand how these two …
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Xiamen study reveals hidden GERD risks
Knowledge-focused CompletedThis study looked at how many people in Xiamen have gastroesophageal reflux disease (GERD) and what factors might increase their risk. Researchers surveyed 1625 adults who had typical reflux symptoms like heartburn. The goal was to better understand the disease's impact and help …
Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC